|
电子期刊 >> 正文 |
摘要:
|
目的:研究、探讨多向药耐药基因(MDR1)及其表达产物P-糖蛋白(P-gp)、拓扑异构酶Ⅱ(TopoⅡ)、谷胱甘肽-S-转移酶(GST-л)和胸苷酸合成酶(Ts)的表达及其临床意义.方法:采用SP法对130例随访10年以上的结、直肠患者进行了癌组织中P-gp、GST-л、Topo Ⅱ和TS的表达,并分析与临床预后的关系.结果:GST-л的表达与UICC分期有关(P=0.022),而与组织类型、浸润深度及淋巴结转移无关:Pgp、TopoⅡ和TS的表达与上述参数均无关(P>0.05).经多因素Cox比例风险模型分析显示,UICC分期、组织类型及GST-Ⅱ、TopoⅡ的表达与结直肠癌患者术后生存率有关(P<0.05).结论:检测结直肠癌中P-gp、GST-x、TopoⅡ和TS的表达,对肿瘤化疗药物的选择具有重要临床意义;UICC分期、组织类型及GST-Ⅱ、TopoⅡ的表达似可作为结直肠癌患者独立的预后因素.
|
|
基金项目:
|
|
作者简介:
|
|
参考文献:
|
耿少卿 生物技术在病理学中的研究进展 1997 Beahrs oH Staging of cancer of the colon and rectum 1992 Gottesman MM.Pastan Ⅰ Biochemistry of multidrug resitance mediated by the multidrug transporter 1993 Weinstein RS.Jakate SM.Dominguez JM Relationship of the expression of the multidrug resistance gene product(p- glycoprotein)in human colon carcinoma to local tumor aggressivegess and 1ymphnode metastasis 1991 耿少卿.翟瑞仁 P 53基因异常表达与肿瘤多向耐药性的相关研究 [期刊论文] -中国冶金工业医学杂志2002(3) Sutoh I.Kohno H.Nakashima Y Concurrent expressions of metallothioncin ,glutathione-s- transferase- л,and p- glycoprotein in colorectal cancers 2000(2) Tokunaga Y.Hosogi H.Hoppou T Effects of MDR1 / p-glycoprotein expression on prognosis in advanced colorectal cancer after surgery 2001(4) Morse MA The ro 1 e of glutathione-S-transferase-л in col orectalcancer:friend or foe? 2001(4) Dogru - Abbasoglu S.Mutlu - Turkoglu U.Turkoglu S Glutathione - s- transferase - л in malignant tissues and plasMa of human c010rectal and gastric cancers 2002(2) Schneider E.Hsiang YH.Liu LF DNA topoiso Merases as anticancer drug targets 1990(2) Nakopoulou L.Zervas A.Lazaris AC Predictive value of topoisoMerase Ⅱ alpha immunostaining in urothe Ⅰ ial bladdercarcigoma 2001(4) 张建兵.陈莉.韩枋.于兰.何松.周建云 c-erbB-2过表达、nm23低表达与结直肠癌预后不良的关系 [期刊论文] -中华病理学杂志2003(2) Johnston PG.Benson AB.Catalano P Thymidylate synthase protein expression in primary colorectal cancer: lack of correlation with outcome and response to fluorouracil in metastatic di sease sites 2003(5)
|
服务与反馈:
|
【文章下载】【加入收藏】
|
|
|
|
|
|
|